An attempt to establish and apply global benchmarks for liver resection of malignant hepatic tumors
Surgery · 2023
DOI: 10.1016/j.surg.2023.08.024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Surgery, 2023. Verfasst von Laura Alaimo und 27 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Division of Surgical Oncology, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Cholangiocarcinoma, Bile Duct Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Benchmarking is a process of continuous self-evaluation and comparison with best-in-class hospitals to guide quality improvement initiatives. We sought to define global benchmarks relative to liver resection for malignancy and to assess their achievement in hospitals in the United States. METHODS: Patients who underwent curative-intent liver resection for hepatocellular carcinoma, intrahepatic cholangiocarcinoma, or colorectal or neuroendocrine liver metastases between 2000 and 2019 were identified from an international multi-institutional database. Propensity score matching was conducted to balance baseline characteristics between open and minimally invasive approaches. Best-in-class hospitals were defined relative to the achievement rate of textbook oncologic outcomes and case volume. Benchmark values were established relative to best-in-class institutions. The achievement of benchmark values among hospitals in the National Cancer Database was then assessed. RESULTS: Among 2,624 patients treated at 20 centers, a majority underwent liver resection for hepatocellular carcinoma (n = 1,609, 61.3%), followed by colorectal liver metastases (n = 650, 24.8%), intrahepatic cholangiocarcinoma (n = 299, 11.4%), and neuroendocrine liver metastases (n = 66, 2.5%). Notably, 1,947 (74.2%) patients achieved a textbook oncologic outcome. After propensity score matching, 6 best-in-class hospitals with the highest textbook oncologic outcome rates (≥75.0%) were identified. Benchmark values were calculated for margin positivity (≤11.7%), 30-day readmission (≤4.1%), 30-day mortality (≤1.6%), minor postoperative complications (≤24.7%), severe complications (≤12.4%), and failure to achieve the textbook oncologic outcome (≤22.8%). Among the National Cancer Database hospitals, global benchmarks for margin positivity, 30-day readmission, 30-day mortality, severe complications, and textbook oncologic outcome failure were achieved in 62.9%, 27.1%, 12.1%, 7.1%, and 29.3% of centers, respectively. CONCLUSION: These global benchmarks may help identify hospitals that may benefit from quality improvement initiatives, aiming to improve patient safety and surgical oncologic outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Surgery, Division of Surgical Oncology, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH; Department of Surgery, University of Verona, Italy.
- Department of Surgery, Division of Surgical Oncology, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH.
- Department of Surgery, University of Verona, Italy.
- Department of Surgery, Ospedale San Raffaele, Milan, Italy.
- Department of Surgery, Johns Hopkins Hospital, Baltimore, MD.
- Department of Surgery, University of Virginia, Charlottesville, VA.
Zitieren
APA
Alaimo, L., Moazzam, Z., Lima, H. A., Endo, Y., Ruzzenente, A., Guglielmi, A., Ratti, F., Aldrighetti, L., Weiss, M., Bauer, T. W., Alexandrescu, S., Popescu, I., Poultsides, G. A., Maithel, S. K., Marques, H. P., Martel, G., Pulitano, C., Shen, F., Cauchy, F., …, & Pawlik, T. M. (2023). An attempt to establish and apply global benchmarks for liver resection of malignant hepatic tumors. Surgery. https://doi.org/10.1016/j.surg.2023.08.024
Vancouver
Alaimo L, Moazzam Z, Lima HA, Endo Y, Ruzzenente A, Guglielmi A, et al. An attempt to establish and apply global benchmarks for liver resection of malignant hepatic tumors. Surgery. 2023. doi:10.1016/j.surg.2023.08.024
BibTeX
@article{Alaimo2023,
author = {Alaimo, Laura and Moazzam, Zorays and Lima, Henrique A and Endo, Yutaka and Ruzzenente, Andrea and Guglielmi, Alfredo and Ratti, Francesca and Aldrighetti, Luca and Weiss, Matthew and Bauer, Todd W and Alexandrescu, Sorin and Popescu, Irinel and Poultsides, George A and Maithel, Shishir K and Marques, Hugo P and Martel, Guillaume and Pulitano, Carlo and Shen, Feng and Cauchy, François and Koerkamp, Bas Groot and Endo, Itaru and Kitago, Minoru and Aucejo, Federico and Sasaki, Kazunari and Fields, Ryan C and Hugh, Tom and Lam, Vincent and Pawlik, Timothy M},
title = {An attempt to establish and apply global benchmarks for liver resection of malignant hepatic tumors},
journal = {Surgery},
year = {2023},
doi = {10.1016/j.surg.2023.08.024}
}
EUVIMED